$VHC
VirnetX Holding Corp

2023 Q4 Form 10-Q Financial Statement

#000114036123052446 Filed on November 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $0.00 $3.000K $5.000K
YoY Change -100.0% -25.0% -54.55%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Gross Profit $0.00 $0.00 $5.000K
YoY Change -100.0% -100.0% -101.45%
Gross Profit Margin 0.0% 100.0%
Selling, General & Admin $5.406M $4.420M $5.348M
YoY Change 1.08% 6.69% 14.4%
% of Gross Profit 106960.0%
Research & Development $2.372M $1.218M $2.708M
YoY Change -12.41% 0.16% 27.44%
% of Gross Profit 54160.0%
Depreciation & Amortization $9.000K $0.00 $2.000K
YoY Change 350.0% -100.0% 100.0%
% of Gross Profit 40.0%
Operating Expenses $7.778M $5.638M $8.056M
YoY Change -3.45% 5.21% 18.47%
Operating Profit -$7.778M -$5.635M -$8.051M
YoY Change -3.39% 5.23% 12.7%
Interest Expense $671.0K $720.0K $1.031M
YoY Change -34.92% 22.24% 8491.67%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$7.107M -$4.919M -$7.020M
YoY Change 1.24% 3.21% -1.57%
Income Tax $0.00 -$1.000K $17.20M
% Of Pretax Income
Net Earnings -$7.107M -$4.918M -$24.22M
YoY Change -70.66% 14.91% 151.69%
Net Earnings / Revenue -163933.33% -484460.0%
Basic Earnings Per Share -$1.36
Diluted Earnings Per Share -$2.00 -$1.36 -$0.34
COMMON SHARES
Basic Shares Outstanding 3.618M 71.64M 71.42M
Diluted Shares Outstanding 3.612M

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.55M $61.03M $152.0M
YoY Change -64.78% -61.62% -10.19%
Cash & Equivalents $26.29M $27.85M $86.56M
Short-Term Investments $27.26M $33.18M $65.46M
Other Short-Term Assets $282.0K $400.0K $224.0K
YoY Change 25.89% 8.11% 10.34%
Inventory
Prepaid Expenses
Receivables $2.000K $2.000K $14.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $53.83M $61.47M $152.3M
YoY Change -64.65% -61.43% -10.17%
LONG-TERM ASSETS
Property, Plant & Equipment $67.00K $6.000K $11.00K
YoY Change 509.09% -53.85% -38.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.500M $2.000M
YoY Change
Other Assets $535.0K $0.00 $703.0K
YoY Change -23.9% -100.0% -95.87%
Total Long-Term Assets $6.581M $2.444M $714.0K
YoY Change 821.71% -86.37% -95.81%
TOTAL ASSETS
Total Short-Term Assets $53.83M $61.47M $152.3M
Total Long-Term Assets $6.581M $2.444M $714.0K
Total Assets $60.41M $63.91M $153.0M
YoY Change -60.51% -63.96% -17.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $440.0K $1.200M $373.0K
YoY Change 17.96% -18.75% 10.36%
Accrued Expenses $316.0K $400.0K $311.0K
YoY Change 1.61% 8.99% -50.24%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.254M $1.601M $731.0K
YoY Change 71.55% -15.74% -28.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.145M $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $3.145M $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.254M $1.601M $731.0K
Total Long-Term Liabilities $3.145M $0.00 $0.00
Total Liabilities $4.399M $1.601M $731.0K
YoY Change 501.78% -15.91% -31.49%
SHAREHOLDERS EQUITY
Retained Earnings -$186.5M -$179.4M -$87.20M
YoY Change 113.88% 184.87% 71.19%
Common Stock $0.00 $0.00 $7.000K
YoY Change -100.0% -100.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $56.01M $62.31M $152.2M
YoY Change
Total Liabilities & Shareholders Equity $60.41M $63.91M $153.0M
YoY Change -60.51% -63.96% -17.98%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income -$7.107M -$4.918M -$24.22M
YoY Change -70.66% 14.91% 151.69%
Depreciation, Depletion And Amortization $9.000K $0.00 $2.000K
YoY Change 350.0% -100.0% 100.0%
Cash From Operating Activities -$6.973M -$3.300M -$7.086M
YoY Change -1.59% 31.42% 123.6%
INVESTING ACTIVITIES
Capital Expenditures $65.00K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $5.506M $5.200M -$12.16M
YoY Change -145.29% -127.57% 325.85%
Cash From Investing Activities $5.441M $5.200M -$12.16M
YoY Change -144.75% -127.57% 325.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.00K 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -6.973M -3.300M -7.086M
Cash From Investing Activities 5.441M 5.200M -12.16M
Cash From Financing Activities -40.00K 0.000 0.000
Net Change In Cash -1.572M 1.900M -19.24M
YoY Change -91.83% -108.89% 219.46%
FREE CASH FLOW
Cash From Operating Activities -$6.973M -$3.300M -$7.086M
Capital Expenditures $65.00K $0.00
Free Cash Flow -$7.038M -$7.086M
YoY Change -0.68% 123.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 vhc Licensing Costs
LicensingCosts
0
vhc Licensing Costs
LicensingCosts
0
vhc Licensing Costs
LicensingCosts
-4000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-58716000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86561000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
142018000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27845000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105805000
CY2023Q3 vhc Licensing Costs
LicensingCosts
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33852
dei Entity Registrant Name
EntityRegistrantName
VirnetX Holding Corp
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0390628
dei Entity Address Address Line1
EntityAddressAddressLine1
308 Dorla Court
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 206
dei Entity Address City Or Town
EntityAddressCityOrTown
Zephyr Cove
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89448
dei City Area Code
CityAreaCode
775
dei Local Phone Number
LocalPhoneNumber
548-1785
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
VHC
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
us-gaap Net Income Loss
NetIncomeLoss
-20764000
us-gaap Net Income Loss
NetIncomeLoss
-12037000
us-gaap Depreciation
Depreciation
5000
us-gaap Depreciation
Depreciation
5000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1171000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
810000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1139000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
99000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
97000
vhc Increase Decrease In Accrued Licensing Costs
IncreaseDecreaseInAccruedLicensingCosts
0
vhc Increase Decrease In Accrued Licensing Costs
IncreaseDecreaseInAccruedLicensingCosts
-355000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-39000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-44000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17757000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9807000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
36330000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
36737000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
66811000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
10360000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
30481000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26377000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-36213000
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3618431
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2070000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2464000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-50000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-98000
us-gaap Payments Of Dividends
PaymentsOfDividends
71429000
us-gaap Payments Of Dividends
PaymentsOfDividends
0
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
29000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-71440000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001082324
vhc Concentration Risk Number Of Financial Institutions
ConcentrationRiskNumberOfFinancialInstitutions
2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2023Q3 vhc Cash And Available For Sale Securities Amortized Cost Basis
CashAndAvailableForSaleSecuritiesAmortizedCostBasis
61118000
CY2023Q3 vhc Cash And Available For Sale Securities Fair Value Disclosure
CashAndAvailableForSaleSecuritiesFairValueDisclosure
61028000
CY2022Q4 vhc Cash And Available For Sale Securities Amortized Cost Basis
CashAndAvailableForSaleSecuritiesAmortizedCostBasis
152400000
CY2022Q4 vhc Cash And Available For Sale Securities Fair Value Disclosure
CashAndAvailableForSaleSecuritiesFairValueDisclosure
152023000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4919000
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-79000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20843000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0038
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-486000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4766000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.103
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1171000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13208000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.083
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2023Q3 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
175000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
225757
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-4918000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4280000
us-gaap Net Income Loss
NetIncomeLoss
-20764000
us-gaap Net Income Loss
NetIncomeLoss
-12037000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3612000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3571000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3586000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3565000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3612000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3571000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3586000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3565000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.36
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.79
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.38
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.36
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.79
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.38
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
348729
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
348729
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
372156
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
372156

Files In Submission

Name View Source Status
vhc-20230930_cal.xml Edgar Link unprocessable
0001140361-23-052446-index-headers.html Edgar Link pending
0001140361-23-052446-index.html Edgar Link pending
0001140361-23-052446.txt Edgar Link pending
0001140361-23-052446-xbrl.zip Edgar Link pending
ef20012484_10q.htm Edgar Link pending
ef20012484_ex31-1.htm Edgar Link pending
ef20012484_ex31-2.htm Edgar Link pending
ef20012484_ex32-1.htm Edgar Link pending
ef20012484_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logo_virtnetcx.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ef20012484_10q_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vhc-20230930.xsd Edgar Link pending
vhc-20230930_def.xml Edgar Link unprocessable
vhc-20230930_lab.xml Edgar Link unprocessable
vhc-20230930_pre.xml Edgar Link unprocessable